Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Arixtra
2. Fondaparinux
3. Quixidar
1. 114870-03-0
2. Arixtra
3. Quixidar
4. Fondaparin Sodium
5. Sr-90107a
6. Org 31540
7. Sr 90107a
8. Fondaparinux Sodium For Assay
9. Org-31540
10. Fondaparinux Sodium Identification
11. X0q6n9usoz
12. Ic-851589
13. Xantidar
14. Arixtra (tn)
15. Unii-x0q6n9usoz
16. Fondaparinux Sodium [usan]
17. Fondaparinux Sodium [usan:inn:ban]
18. Gsk-576428
19. Ic 85158
20. Sr-90107
21. Chembl1200644
22. Fondaparinux Sodium [mi]
23. Fondaparinux Sodium [inn]
24. Fondaparinux Sodium [jan]
25. Dtxsid501027612
26. Fondaparinux Sodium [mart.]
27. Fondaparinux Sodium (jan/usp/inn)
28. Fondaparinux Sodium [usp-rs]
29. Fondaparinux Sodium [who-dd]
30. Natural Heparin Pentasaccharide Sodium
31. Akos005146286
32. Fondaparinux Sodium [ema Epar]
33. Ccg-270693
34. Fondaparinux Sodium [orange Book]
35. As-80003
36. Fondaparinux Sodium [usp Monograph]
37. C71476
38. D01844
39. A803253
40. Q421218
41. Alpha-d-glucopyranoside, Methyl O-2-deoxy-6-o-sulfo-2-(sulfoamino)-alpha-d-glucopyranosyl-(1-4)-o-beta-d-glucopyranuronosyl(1-4)-o-2-deoxy-3,6-di-o-sulfo-2-(sulfoamino)-alpha-d-glucopyranosyl-(1-4)-o-2-o-sulfo-alpha-l-idopyranuronosyl-(1-4)-2-deoxy-2-(sulfoamino)-, 6-(hydrogen Sulfate), Decasodium Salt
42. Decasodium 6-[6-[2-carboxylato-4-hydroxy-6-[4-hydroxy-6-methoxy-5-(sulfonatoamino)-2-(sulfonatooxymethyl)tetrahydropyran-3-yl]oxy-5-sulfonatooxy-tetrahydropyran-3-yl]oxy-5-(sulfonatoamino)-4-sulfonatooxy-2-(sulfonatooxymethyl)tetrahydropyran-3-yl]oxy-3-[4;fondaparinux Sodium
43. Methly O-2-deoxy-6-o-sulfo-2-(sulfoamino)-alpha-d-glucopyranosyl-(1-4)-o-beta-d-glucopyranuronosyl-(1-4)-o-2-deoxy-3,6-di-o-sulfo-2-(sulfoamino)-alpha-d-glucopyranosyl-(1-4)-o-2-o-sulfo-alpha-l-idopyranuronosyl-(1-4)-2-deoxy-6-o-sulfo-2-(sulfoamino)-alpha-d-glucopyranoside, Decasodium Salt
Molecular Weight | 1728.1 g/mol |
---|---|
Molecular Formula | C31H43N3Na10O49S8 |
Hydrogen Bond Donor Count | 9 |
Hydrogen Bond Acceptor Count | 52 |
Rotatable Bond Count | 20 |
Exact Mass | 1726.7707769 g/mol |
Monoisotopic Mass | 1726.7707769 g/mol |
Topological Polar Surface Area | 901 Ų |
Heavy Atom Count | 101 |
Formal Charge | 0 |
Complexity | 3330 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 25 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 11 |
1 of 4 | |
---|---|
Drug Name | Arixtra |
Drug Label | ARIXTRA (fondaparinux sodium) Injection is a sterile solution containing fondaparinux sodium. It is a synthetic and specific inhibitor of activated Factor X (Xa). Fondaparinux sodium is methyl O-2-deoxy-6-O-sulfo-2-(sulfoamino)--D-glucopyranosyl-(1... |
Active Ingredient | Fondaparinux sodium |
Dosage Form | Injectable |
Route | Subcutaneous |
Strength | 5mg/0.4ml; 2.5mg/0.5ml; 7.5mg/0.6ml; 10mg/0.8ml |
Market Status | Prescription |
Company | Agi |
2 of 4 | |
---|---|
Drug Name | Fondaparinux sodium |
PubMed Health | Fondaparinux (Injection) |
Drug Classes | Anticoagulant |
Drug Label | ARIXTRA (fondaparinux sodium) Injection is a sterile solution containing fondaparinux sodium. It is a synthetic and specific inhibitor of activated Factor X (Xa). Fondaparinux sodium is methyl O-2-deoxy-6-O-sulfo-2-(sulfoamino)--D-glucopyranosyl-(1... |
Active Ingredient | Fondaparinux sodium |
Dosage Form | Injectable |
Route | Subcutaneous |
Strength | 2.5mg/0.5ml; 7.5mg/0.6ml; 5mg/0.4ml; 10mg/0.8ml |
Market Status | Prescription |
Company | Dr Reddys Labs |
3 of 4 | |
---|---|
Drug Name | Arixtra |
Drug Label | ARIXTRA (fondaparinux sodium) Injection is a sterile solution containing fondaparinux sodium. It is a synthetic and specific inhibitor of activated Factor X (Xa). Fondaparinux sodium is methyl O-2-deoxy-6-O-sulfo-2-(sulfoamino)--D-glucopyranosyl-(1... |
Active Ingredient | Fondaparinux sodium |
Dosage Form | Injectable |
Route | Subcutaneous |
Strength | 5mg/0.4ml; 2.5mg/0.5ml; 7.5mg/0.6ml; 10mg/0.8ml |
Market Status | Prescription |
Company | Agi |
4 of 4 | |
---|---|
Drug Name | Fondaparinux sodium |
PubMed Health | Fondaparinux (Injection) |
Drug Classes | Anticoagulant |
Drug Label | ARIXTRA (fondaparinux sodium) Injection is a sterile solution containing fondaparinux sodium. It is a synthetic and specific inhibitor of activated Factor X (Xa). Fondaparinux sodium is methyl O-2-deoxy-6-O-sulfo-2-(sulfoamino)--D-glucopyranosyl-(1... |
Active Ingredient | Fondaparinux sodium |
Dosage Form | Injectable |
Route | Subcutaneous |
Strength | 2.5mg/0.5ml; 7.5mg/0.6ml; 5mg/0.4ml; 10mg/0.8ml |
Market Status | Prescription |
Company | Dr Reddys Labs |
* 1. 5-mg/0. 3-ml and 2. 5-mg/0. 5-ml solution for injection:
Prevention of venous thromboembolic events (VTE) in adults undergoing major orthopaedic surgery of the lower limbs such as hip fracture, major knee surgery or hip-replacement surgery.
Prevention of VTE in adults undergoing abdominal surgery who are judged to be at high risk of thromboembolic complications, such as patients undergoing abdominal cancer surgery.
Prevention of VTE in adult medical patients who are judged to be at high risk for VTE and who are immobilised due to acute illness such as cardiac insufficiency and / or acute respiratory disorders, and / or acute infectious or inflammatory disease.
Treatment of adults with acute symptomatic spontaneous superficial-vein thrombosis of the lower limbs without concomitant deep-vein thrombosis.
* 2. 5-mg/0. 5-ml solution for injection:
Treatment of unstable angina or non-ST-segment-elevation myocardial infarction (UA/NSTEMI) in adult patients for whom urgent (< 120 mins) invasive management (PCI) is not indicated.
infarction (STEMI) in adult patients who are managed with thrombolytics or who initially are to receive no other form of reperfusion therapy.
* 5-mg/0. 4-ml, 7. 5-mg/0. 6-ml and 10-mg/0. 8-ml solution for injection:
Treatment of adults with acute deep-vein thrombosis (DVT) and treatment of acute pulmonary embolism (PE), except in haemodynamically unstable patients or patients who require thrombolysis or pulmonary embolectomy.
1. 5 mg/0. 3 ml and 2. 5 mg/0. 5 ml, solution for injection:
Prevention of Venous Thromboembolic Events (VTE) in patients undergoing major orthopaedic surgery of the lower limbs such as hip fracture, major knee surgery or hip replacement surgery.
Prevention of Venous Thromboembolic Events (VTE) in patients undergoing abdominal surgery who are judged to be at high risk of thromboembolic complications, such as patients undergoing abdominal cancer surgery (see section 5. 1).
Prevention of Venous Thromboembolic Events (VTE) in medical patients who are judged to be at high risk for VTE and who are immobilised due to acute illness such as cardiac insufficiency and/or acute respiratory disorders, and/or acute infectious or inflammatory disease.
2. 5 mg/0. 5 ml, solution for injection:
Treatment of unstable angina or non-ST segment elevation myocardial infarction (UA/NSTEMI) in patients for whom urgent (< 120 mins) invasive management (PCI) is not indicated (see sections 4. 4 and 5. 1).
Treatment of ST segment elevation myocardial infarction (STEMI) in patients who are managed with thrombolytics or who initially are to receive no other form of reperfusion therapy.
5 mg/0. 4 ml, 7. 5 mg/0. 6 ml and 10 mg/0. 8 ml solution for injection:
Treatment of acute Deep Vein Thrombosis (DVT) and treatment of acute Pulmonary Embolism (PE), except in haemodynamically unstable patients or patients who require thrombolysis or pulmonary embolectomy.
Factor Xa Inhibitors
Endogenous factors and drugs that inhibit or block the activity of FACTOR XA. (See all compounds classified as Factor Xa Inhibitors.)
B01AX05
B01AX05
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15259
Submission : 2001-01-22
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 28762
Submission : 2014-11-30
Status : Active
Type : II
Registrant Name : Handok Co., Ltd.
Registration Date : 2013-03-29
Registration Number : 20130329-193-I-126-01
Manufacturer Name : Aspen notre dame de bondeville@Ajinomoto Omnichem@Aspen Oss BV@ORIL Industrie
Manufacturer Address : 1, rue de l'Abbaye, 76960 Notre Dame De Bondeville@Cooppallaan 91, Wetteren, Oost-Vlaanderen, B-9230, Belgium_x000D_ (Manufacturer 1)@Kloosterstraat6 5349 AB OSS, The Netherlands_x000D_ (Manufacturer 2)@13, rue Auguste Desgenétais, BOLBEC, 76210, France
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-04-04
Pay. Date : 2022-03-29
DMF Number : 22579
Submission : 2009-02-26
Status : Active
Type : II
Date of Issue : 2022-06-15
Valid Till : 2025-06-16
Written Confirmation Number : WC-0034
Address of the Firm :
NDC Package Code : 55111-839
Start Marketing Date : 2009-02-26
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-02-06
Pay. Date : 2016-09-06
DMF Number : 30767
Submission : 2016-07-15
Status : Active
Type : II
NDC Package Code : 62227-006
Start Marketing Date : 2019-02-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-02-03
Pay. Date : 2022-12-12
DMF Number : 37729
Submission : 2022-12-16
Status : Active
Type : II
NDC Package Code : 62227-006
Start Marketing Date : 2019-02-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25093
Submission : 2011-06-30
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37499
Submission : 2022-10-19
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-02-05
Pay. Date : 2013-08-30
DMF Number : 27336
Submission : 2013-09-27
Status : Active
Type : II
NDC Package Code : 57884-0026
Start Marketing Date : 2013-09-26
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (180g/180g)
Marketing Category : BULK INGREDIENT
Registrant Name : Handok Co., Ltd.
Registration Date : 2013-03-29
Registration Number : 20130329-193-I-126-01
Manufacturer Name : Aspen notre dame de bondevil...
Manufacturer Address : 1, rue de l'Abbaye, 76960 Notre Dame De Bondeville@Cooppallaan 91, Wetteren, Oost-Vla...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
CAS Number : 114903-05-8
End Use API : Fondaparinux Sodium
About The Company : Headquartered in Fengxian District, Shanghai Minbiotech Co., Ltd. is a company specializing in the R&D and production of advanced pharmaceutical intermediate...
CAS Number : 2466-76-4
End Use API : Fondaparinux Sodium
About The Company : Novick Bio-Sciences is a rapidly-growing Contract Research and Development Organization (CRDO) providing chemistry and formulation development services to Globa...
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Global Sales Information
RX/OTC/DISCN : Class A
Dosage Form : Fondaparinux 1,5Mg 0,3Ml 10 Unit...
Dosage Strength : 10 SYRINGES SC 1.5 mg 0.3 ml
Price Per Pack (Euro) : 40.47
Published in :
Country : Italy
RX/OTC/DISCN : Class A
RX/OTC/DISCN : Class A
Dosage Form : Fondaparinux 10Mg 0,8Ml 10 Units...
Dosage Strength : 10 SYRINGES SC 10 mg 0.8 ml
Price Per Pack (Euro) : 207.01
Published in :
Country : Italy
RX/OTC/DISCN : Class A
RX/OTC/DISCN : Class A
Dosage Form : Fondaparinux 2,5Mg 0,5Ml 10 Init...
Dosage Strength : 10 SYRINGES SC 2.5 mg 0.5 ml
Price Per Pack (Euro) : 67.45
Published in :
Country : Italy
RX/OTC/DISCN : Class A
RX/OTC/DISCN : Class A
Dosage Form : Fondaparinux 5Mg 0.4 Ml 10 Units...
Dosage Strength : 10 SYRINGES SC 5 mg 0.4 ml
Price Per Pack (Euro) : 138.04
Published in :
Country : Italy
RX/OTC/DISCN : Class A
RX/OTC/DISCN : Class A
Dosage Form : Fondaparinux 7,5Mg 0,6Ml 10 Unit...
Dosage Strength : 10 SYRINGES SC 7.5 mg 0.6 ml
Price Per Pack (Euro) : 207.01
Published in :
Country : Italy
RX/OTC/DISCN : Class A
RX/OTC/DISCN :
Dosage Form : Injection fluid, resolution
Dosage Strength : 10 mg/0.8 ml
Price Per Pack (Euro) : 38.61
Published in :
Country : Norway
RX/OTC/DISCN :
RX/OTC/DISCN :
Dosage Form : Injection fluid, resolution
Dosage Strength : 10 mg/0.8 ml
Price Per Pack (Euro) : 123.27
Published in :
Country : Norway
RX/OTC/DISCN :
RX/OTC/DISCN :
Dosage Form : Injection fluid, resolution
Dosage Strength : 10 mg/0.8 ml
Price Per Pack (Euro) : 174.06
Published in :
Country : Norway
RX/OTC/DISCN :
RX/OTC/DISCN :
Dosage Form : Injection fluid, resolution
Dosage Strength : 2.5 mg/0.5 ml
Price Per Pack (Euro) : 14.179
Published in :
Country : Norway
RX/OTC/DISCN :
RX/OTC/DISCN :
Dosage Form : Injection fluid, resolution
Dosage Strength : 2.5 mg/0.5 ml
Price Per Pack (Euro) : 40.667
Published in :
Country : Norway
RX/OTC/DISCN :
Market Place
Reply
13 Jul 2023
Reply
19 Nov 2022
Reply
24 Sep 2022
Reply
06 Jul 2022
Reply
09 May 2022
Reply
24 Feb 2022
Reply
24 Feb 2021
Reply
19 Mar 2020
Reply
08 Dec 2018
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
Fondaparinux Sodium System Suitability Mixtur...
CAS Number : N/A
Quantity Per Vial :
Price ($) : 730
Catalog Number : 1282730
Current Lot : F0M177
Previous Lot :
NDC Code :
Fondaparinux Sodium System Suitability Mixtur...
CAS Number : N/A
Quantity Per Vial :
Price ($) : 730
Catalog Number : 1282729
Current Lot : F0M176
Previous Lot :
NDC Code :
Fondaparinux Sodium Identification (30 mg)
CAS Number : 114870-03-0
Quantity Per Vial :
Price ($) : 375
Catalog Number : 1282718
Current Lot : F0M501
Previous Lot :
NDC Code :
Fondaparinux Sodium for Assay (0.6 mL) (COLD ...
CAS Number : 114870-03-0
Quantity Per Vial :
Price ($) : 280
Catalog Number : 1282707
Current Lot : R065E0
Previous Lot : F0M178 (30-SEP-2017)
NDC Code :
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?